1717; 307 years ago (1717) as Fushimiya Ichibei apothecary
Founder
Ichibei Ono I
Headquarters
Chuo-ku, Osaka, 541-8564
,
Japan
Area served
Worldwide
Key people
Gyo Sagara (President and CEO)
Products
Pharmaceuticals
Diagnostic reagents
Revenue
USD 6.3 billion (FY 2023)
Net income
USD 848.1 million (FY 2023)
Number of employees
3,687 (2023)
Website
Official website
Footnotes / references [1][2][3]
Ono Pharmaceutical's headquarters in Chūō-ku, Osaka, Japan
Ono Pharmaceutical Co., Ltd. (小野薬品工業株式会社, Ono Yakuhin Kōgyō Kabushiki-gaisha) is one of the largest pharmaceutical companies in Japan. It is headquartered in Chuo-ku, Osaka, Japan, with its major plants in Higashinari-ku, Osaka, and Fujinomiya, Shizuoka.,[4] and its central research institute at Minase, Shimamoto-cho, Mishima District, Osaka.[5]
Ono Pharmaceutical's roots go back to 1717 when Ichibei Ono (Japanese: 小野市兵衛) started his dealer business of pharmaceuticals in Osaka. His business expanded and changed its name a few times, and became Ono Pharmaceutical Industrial Co., Ltd. (Japanese: 小野薬品工業株式会社) in 1948.[6]
Ono has been listed in Tokyo Stock Exchange since 1963. Its consolidated earnings in the half year ending in March 2018 were 16 billion Japanese yen.[7]
Nivolumab, the cancer drug based on the research of Prof.Dr. Tasuku Honjo of Kyoto University, who received the Nobel Prize later in 2018, is marketed by both Ono Pharmaceutical and Bristol-Myers Squibb.[8]
In 2024, Harvard University and Ono Pharmaceutical (ONO) entered into a joint research and drug development agreement. Under it, promising projects to test therapeutic targets will be selected over 5 years under the guidance of Harvard's Office of Technology Development, and ONO will fund the work.[9]
^"Company Profile". Ono Pharmaceutical. Retrieved January 30, 2019.
^"Company Profile". Nikkei Asian Review. Nikkei Inc. Retrieved January 30, 2019.
^"About the company". Financial Times. Retrieved January 30, 2019.
^Ono Pharmaceutical - Manufacturing
^Ono Pharmaceutical - Research & Development
^P. Reed Maurer (January 25, 2013). They Do Well Who Do Good: Insights into Japan's Pharmaceutical Industry. p. 132. ISBN 978-1-4669-5347-5.
^"Company Overview of Ono Pharmaceutical Co., Ltd". bloomberg.com. Retrieved October 4, 2018.
^"Spotlight on New Cancer Immunotherapy: Ono Pharmaceutical's Opdivo". Nippon.com. February 9, 2016. Retrieved October 4, 2018.
^"Harvard partners with Ono Pharma to accelerate development of novel therapeutics". TechTransferCentral. March 18, 2024.
and 24 Related for: Ono Pharmaceutical information
OnoPharmaceutical Co., Ltd. (小野薬品工業株式会社, Ono Yakuhin Kōgyō Kabushiki-gaisha) is one of the largest pharmaceutical companies in Japan. It is headquartered...
lymphoma. In addition, tirabrutinib is in clinical development by OnoPharmaceutical and Gilead Sciences in the United States, Europe, and Japan for autoimmune...
the parathyroid gland. Parsabiv is currently owned by Amgen and OnoPharmaceuticals in Japan. Etelcalcetide is used for the treatment of secondary hyperparathyroidism...
under intellectual property of OnoPharmaceutical regarding PD-1 and under a research collaboration entered in 2005 between Ono and Medarex.[citation needed]...
National Ionity Nanocare Nikon Nintendo Nissan NTT DoCoMo OnoPharmaceutical Otsuka Pharmaceutical Co. Pioneer Platinum Guild International Pola Seiko Epson...
Health Organization (2017). "International Nonproprietary Names for Pharmaceutical Substances (INN)" (PDF). WHO Drug Information. 31 (2). "PDR001". Immuno-Oncology...
Spike Chunsoft Square and Enix - Merged to form Square Enix Daiichi Pharmaceutical Co. and Sankyo Co. - Merged to form Daiichi Sankyo Takata Corporation...
since 1985 under the trade name Foipan Tablets. The manufacturer is OnoPharmaceutical. The drug is used in the treatment of some forms of cancer and is...
in nature. The name nitrite also refers to organic compounds having the –ONO group, which are esters of nitrous acid. Sodium nitrite is made industrially...
Squibb Co and OnoPharmaceutical Co Ltd to resolve all global patent-infringement litigation related to its cancer drug, Keytruda. Bristol and Ono, which co-developed...
Oncothyreon. In 2011, OnoPharmaceutical Company, of Japan, acquired a co-development and co-marketing license for tecemotide in Japan; Ono paid Merck KGaA...
Imaki K, Arai Y, Okegawa T, "Derivatives of p-substituted phenyl ester of pivalic acid", issued 21 May 1991, assigned to OnoPharmaceutical Co Ltd v t e...
Regeneron Pharmaceuticals Purchases Avon in Suffern For $38.875 Million, To be Used For Research & Development Laboratories "Novartis, Ono Latest to Announce...
marketed in these countries. Instead, epristeride was developed by OnoPharmaceutical and introduced for the treatment of BPH in China in 2000. Epristeride...
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies...
Recording the Music of The Beatles. According to Emerick, Lennon's wife Yoko Ono was in the recording studio and at one point helped herself to Harrison's...
An antispasmodic (synonym: spasmolytic) is a pharmaceutical drug or other agent that suppresses muscle spasms. One type of antispasmodics is used for smooth...
Satoshi Ohno (大野 智, Ōno Satoshi, born November 26, 1980) is a Japanese idol, singer, actor, radio host, artist, dancer, and choreographer. He is the lead...
Research UK, LifeArc and pharmaceutical companies Eisai and Lilly. In March 2019, LifeArc joined with Cancer Research UK and Ono Pharma to progress new...
biomarkers) that predict toxicity or the genetic susceptibility to it. In pharmaceutical research, toxicogenomics is defined as the study of the structure and...
traditional uses, chemical composition, and biological activity". Current Pharmaceutical Biotechnology. 16 (6): 506–16. doi:10.2174/138920101606150407112903...
1972 and launched by Dainippon Sumitomo Pharma (formerly Dainippon Pharmaceutical) in 1989 as Excegran in Japan. It was marketed by Élan in the United...
in that former Feyenoord midfielder Shinji Ono began his professional career playing for Urawa Reds. Ono returned for the 2006 season for a second stint...
Global Information
USD 6.3 billion (FY 2023)